Literature DB >> 21553702

Ultra-wide-field green-light (532-nm) autofluorescence imaging in chronic Vogt-Koyanagi-Harada disease.

Florian M Heussen1, Daniel V Vasconcelos-Santos, Rajeev R Pappuru, Alexander C Walsh, Narsing A Rao, Srinivas R Sadda.   

Abstract

BACKGROUND AND
OBJECTIVE: To assess the prevalence of peripheral fundus autofluorescence (FAF) abnormalities in chronic Vogt-Koyanagi-Harada disease (VKH). PATIENTS AND METHODS: A retrospective review of cases at the Doheny Eye Institute between December 2009 and April 2010. Patients with chronic VKH who had ultra-wide-field FAF and pseudo-color imaging performed were included. All images were reviewed independently by two reading center certified retina specialists.
RESULTS: Twenty eyes of 10 patients were included in this analysis. Fourteen eyes of 7 patients (70%) showed peripheral changes on FAF images outside the posterior pole. Three different patterns were observed: multifocal hypofluorescent spots (n = 11 eyes), hyperfluorescent spots (n = 8 eyes), and a unique lattice-like pattern in both eyes of one patient. There were noticeable disparities between FAF and color images.
CONCLUSION: Peripheral FAF abnormalities are frequent in chronic VKH and are readily revealed by wide-field FAF imaging and manifesting with distinct patterns. Further investigation in prospective studies is warranted. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553702     DOI: 10.3928/15428877-20110505-01

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  14 in total

1.  Prevalence of peripheral abnormalities on ultra-widefield greenlight (532 nm) autofluorescence imaging at a tertiary care center.

Authors:  Florian M Heussen; Colin S Tan; SriniVas R Sadda
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-21       Impact factor: 4.799

2.  Visualization of the optic fissure in short-wavelength autofluorescence images of the fundus.

Authors:  Tobias Duncker; Jonathan P Greenberg; Janet R Sparrow; R Theodore Smith; Harry A Quigley; François C Delori
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-28       Impact factor: 4.799

3.  Retinal imaging in uveitis.

Authors:  Vishali Gupta; Hassan A Al-Dhibi; J Fernando Arevalo
Journal:  Saudi J Ophthalmol       Date:  2014-03-05

4.  ULTRA-WIDE-FIELD FUNDUS AUTOFLUORESCENCE FINDINGS IN PATIENTS WITH ACUTE ZONAL OCCULT OUTER RETINOPATHY.

Authors:  Amde Selassie Shifera; Mark E Pennesi; Paul Yang; Phoebe Lin
Journal:  Retina       Date:  2017-06       Impact factor: 4.256

Review 5.  Clinical application of ultra-widefield fundus autofluorescence.

Authors:  Amin Xu; Changzheng Chen
Journal:  Int Ophthalmol       Date:  2020-10-11       Impact factor: 2.031

Review 6.  Use of fundus autofluorescence in the diagnosis and management of uveitis.

Authors:  Annal D Meleth; H Nida Sen
Journal:  Int Ophthalmol Clin       Date:  2012

7.  [Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].

Authors:  Shuwei Tian; Jing Yao; Jianming Wang; Jie Zhang; Aiyi Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

Review 8.  Ancillary investigations in uveitis.

Authors:  Vishali Gupta; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2013-06       Impact factor: 1.848

9.  Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study.

Authors:  Felipe T da Silva; Carlos E Hirata; Viviane M Sakata; Edilberto Olivalves; Rony Preti; Sergio L G Pimentel; Andre Gomes; Walter Y Takahashi; Rogerio A Costa; Joyce H Yamamoto
Journal:  BMC Ophthalmol       Date:  2012-08-13       Impact factor: 2.209

10.  Correlation between Retinal Changes and Visual Function in Late-Stage Vogt-Koyanagi-Harada Disease: An Optical Coherence Tomography Study.

Authors:  Min Zhou; Chunhui Jiang; Ruiping Gu; Zhongcui Sun; Nancy Huynh; Qing Chang
Journal:  J Ophthalmol       Date:  2015-08-02       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.